RismadarVoice Reporters
November 18, 2026
The World Health Organisation (WHO) and the Nigerian Academy of Pharmacy have called for increased investment in domestic pharmaceutical manufacturing to reduce Nigeria’s dependence on imported medicines and strengthen national health security.
The call was made on Tuesday during the Academy’s 2026 Annual General Meeting and Investiture of New Fellows, themed “Pharmacy for National Health Security: Advancing Innovation, Medicine Sovereignty and Sustainable Healthcare.”
Delivering a keynote address on behalf of WHO Country Representative Dr Pavel Ursu, Dr Akinola Fatiregun emphasised the importance of building a pharmaceutical industry capable of meeting Nigeria’s healthcare requirements.
He highlighted the Federal Government’s target of producing 70 per cent of the country’s pharmaceutical needs locally by 2030 under the Presidential Initiative for Unlocking the Healthcare Value Chain.

The WHO representative explained that excessive dependence on imported medicines exposes countries to shortages and disruptions during international emergencies and supply-chain crises.
He identified policy development, pharmaceutical research, regulatory science, workforce training, emergency preparedness and medicine safety monitoring as areas requiring stronger collaboration.
Ursu also advocated investment in the local production of active pharmaceutical ingredients, which are essential components used in manufacturing medicines.
He said strengthening domestic manufacturing could improve medicine availability while supporting Nigeria’s efforts to achieve universal health coverage.
President of the Nigerian Academy of Pharmacy, Professor Lere Baale, urged pharmaceutical professionals to combine scientific expertise with innovation, mentorship and collaboration.

Baale maintained that Nigeria possesses the professional talent and industrial potential needed to become a significant pharmaceutical manufacturing centre serving African markets.
However, he stressed that achieving this objective would require coordinated investment, supportive policies and sustained cooperation between government, industry and research institutions.
The ceremony also recognised distinguished pharmaceutical professionals for their contributions to healthcare development.
Founder of Emzor Pharmaceutical Industries, Stella Okoli, received a Lifetime Achievement Award and encouraged younger professionals to gain practical experience in pharmaceutical production.
Former Pharmaceutical Society of Nigeria President Ahmed Yakasai emphasised professional integrity and stronger action against counterfeit and substandard medicines.
The Academy inducted 11 new fellows and conferred honorary fellowships on two individuals.
The stakeholders maintained that expanding domestic pharmaceutical production, strengthening regulatory oversight and improving research capacity would be essential to building a more resilient healthcare system.









